ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

KOD vs JNJ // 10Y YIELD & FRED MACRO BETA

Kodiak Sciences Inc (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: KOD 2 — JNJ 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: JNJ
macro-sensitivity
0.90
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KOD VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC KOD JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 25.50% -60.50 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -2.16% 2.97% -5.13 JNJ /fcf-yield <GO>
Operating Margin -13.30% 34.70% -48.00 JNJ /operating-margins <GO>
Net Profit Margin -13.00% 28.50% -41.50 JNJ /net-margins <GO>
Revenue Growth (YoY) 1.10% 6.00% -4.90 JNJ /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 16.70 5.59 +11.11 KOD /balance-sheet <GO>
Piotroski F-Score Quality 4/9 8/9 -4.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.3 62.1 +5.20 KOD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE 0.90 1.08 -0.18 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 35.0x 23.0x +12.00 JNJ /forward-pe <GO>
Enterprise Scale & Market Cap $6.31B $662.49B -$656.18B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR KOD REV JNJ REV KOD GROSS % JNJ GROSS % KOD FCF JNJ FCF
FY 2025 $0 $94.19B — 67.9% -$136.5M $19.70B
FY 2024 $0 $88.82B — 69.1% -$117.7M $19.84B
FY 2023 $0 $85.16B — — -$154.2M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KOD // BETA 0.90
JNJ // BETA 1.08